Letter by Schmidt et al Regarding Article, "Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study".

HomeCirculationVol. 147, No. 12Letter by Schmidt et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study” No AccessLetterRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessLetterRequest AccessFull TextLetter by Schmidt et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study” Maria Inês Schmidt, Paula A. Bracco and Bruce B. Duncan Maria Inês SchmidtMaria Inês Schmidt https://orcid.org/0000-0002-3837-0731 Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Search for more papers by this author , Paula A. BraccoPaula A. Bracco Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Search for more papers by this author and Bruce B. DuncanBruce B. Duncan https://orcid.org/0000-0002-7491-2630 Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Search for more papers by this author Originally published21 Mar 2023https://doi.org/10.1161/CIRCULATIONAHA.122.062745Circulation. 2023;147:987"Letter by Schmidt et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study”." Circulation, 147(12), p. 987FootnotesCirculation is available at www.ahajournals.org/journal/circReferences1. Tabák AG, Brunner EJ, Lindbohm JV, Singh-Manoux A, Shipley MJ, Sattar N, Kivimäki M. Risk of macrovascular and microvascular disease in diabetes diagnosed using oral glucose tolerance test with and without confirmation by hemoglobin A1c: the Whitehall II cohort study.Circulation. 2022; 146:995–1005. doi: 10.1161/CIRCULATIONAHA.122.059430LinkGoogle Scholar2. Schmidt MI, Bracco P, Canhada S, Guimarães JMN, Barreto SM, Chor D, Griep R, Yudkin JS, Duncan BB. Regression to the mean contributes to the apparent improvement in glycemia 3.8 years after screening: The ELSA-Brasil study.Diabetes Care. 2021; 44:81–88. doi: 10.2337/dc20-2030CrossrefMedlineGoogle Scholar3. American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2022.Diabetes Care. 2021; 45:S17–S38. doi: 10.2337/dc22-S002CrossrefGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails March 21, 2023Vol 147, Issue 12 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.122.062745PMID: 36944034 Originally publishedMarch 21, 2023 PDF download Advertisement SubjectsCADASILMeta AnalysisQuality and Outcomes